[1]
Ko, J.J. et al. 2024. Real-world evaluation of access-driven Canadian treatment sequences in progressive prostate cancer (REACTIVATE). Canadian Urological Association Journal. 18, 7 (Mar. 2024), E194–203. DOI:https://doi.org/10.5489/cuaj.8620.